51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC)
Mantovani, G., Massa, E., Madeddu, C., Gramignano, G., Astara, G., Lusso, M., Cherchi, V., Serpe, R.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81522-3
Date:
July, 2005
File:
PDF, 140 KB
english, 2005